Bayer HealthCare and HealthyWomen launch Family Size Matters initiative
WHIPPANY, N.J. — Bayer HealthCare and HealthyWomen on Thursday launched the Family Size Matters initiative to help educate women who are done, or think they may be done, having children about their family planning, including permanent birth control.
Family Size Matters is launched in partnership with Bayer, HealthyWomen — a leading health information resource for women — and Suzanne Gilberg-Lenz, a board certified OB/GYN.
As part of the Family Size Matters program, Bayer HealthCare surveyed 1,000 women in the United States ages 25 to 45 years who are in committed relationships, are done having children, and are not using permanent birth control. As many as 35% of all the women surveyed reported having a pregnancy scare after deciding they were done having children. And of the 900 women surveyed who are using some form of birth control, 66% are still using the same birth control they used prior to their most recent pregnancy.
“Different birth control methods work well for women in different stages of their reproductive lives. For example, birth control pills might be right for you when you are starting your family, and permanent contraception might be the right option for many patients who are done having children,” stated Gilberg-Lenz. “That’s why it’s so important that women are educated about all their options and discuss them with their partners and doctors, to arrive at an informed decision that works best for them.”
The Bayer survey results indicated that there may be a need for better education about birth control options for women who are done having children. Three-out-of-four of the 900 women surveyed who are done having children and are using temporary forms of birth control stated that they would be interested in learning about permanent birth control from their doctors.
“As a leading health information resource for women, we are thrilled to be partnering with Bayer HealthCare on this initiative, to ensure our readers and women everywhere have access to resources and information on various birth control options and understand the importance of speaking with their healthcare provider about those options,” said Beth Battaglino, president and CEO of HealthyWomen. “I encourage women to visit the program website FamilySizeMatters.com for more information and resources, including an online quiz and tips to help in discussions with a woman’s partner and healthcare provider."
Imágen hair care supports Latinas in Business Awards
TAMPA BAY, Fla. — The Stephan Co., a maker of hair care and skin care products, has announced that its Imágen hair care brand is supporting the Los Angeles Chapter of the National Latina Business Women Association's 11th Annual Latinas in Business Awards.
The awards honor Latinas in the L.A.-area who have excelled in various aspects of the business world. Candidates from across a range of industries are nominated for specific categories by NLBWA-LA members.
Courtesy of the Stephan Company, each of the winners and all 400 attendees at the event will receive Imágen Salon Formula, a new hair care line designed specifically to meet the hair care needs of Latinas.
Currently available at Target, Imágen Salon Formula consists of six, hair care products: shampoo, conditioner, leave-in conditioner, temporary straightener, shine mist and anti-frizz serum.
NABP announces pharmacy domains
MOUNT PROSPECT, Ill. — As the registry operator of the new .pharmacy domain, the National Association of Boards of Pharmacy, under a contract with the Internet Corporation for Assigned Names and Numbers, will soon provide a means for identifying safe online pharmacies and resources.
Under the Association's Registry Agreement, executed with ICANN on June 19, 2014, the new .pharmacy generic top-level Domain will be available only to legitimate online pharmacies and related entities located in the United States or other countries. The Registry Agreement also includes a number of safeguards intended to protect consumers.
NABP plans to launch the .pharmacy gTLD by fall 2014, and is currently operationalizing policies to ensure that only legitimate website operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .pharmacy. These eligibility requirements for the .pharmacy gTLD were developed in partnership with a global coalition of stakeholders and address a shared concern about illegal online drug sellers distributing products.
"Amidst a proliferation of rogue websites selling counterfeit and substandard drug products, the .pharmacy domain will give consumers an easy way to be assured that they are using a safe, legitimate Internet pharmacy," stated NABP president Joseph Adams. "Toward this goal, NABP is very pleased to become an official registry operator under the agreement with ICANN and to be moving forward with steps to launch the new .pharmacy gTLD."
The next step for the .pharmacy gTLD is the registry onboarding process, which includes performance of pre-delegation testing to ensure that NABP and its technical partners have the capacity to operate the new .pharmacy gTLD in a stable and secure manner. Additionally, as the registry operator, NABP will contract with registrars that agree to ensure domain name registrants are in compliance with the established .pharmacy standards.
NABP has been working toward completion of these steps since May 2013 when the .pharmacy proposal passed ICANN's initial evaluation. The Association also has launched an informational website, DotPharmacy.net, which includes program updates and a request-for-information form for entities seeking a .pharmacy gTLD. Application instructions for entities seeking a .pharmacy gTLD will be included on the site to coincide with the launch. In July 2014, NABP will convene a meeting of the .pharmacy gTLD advisory committee to discuss implementation of the program standards and to continue fostering collaborative international partnerships.
NABP continues to monitor websites selling prescription drugs to patients in the US and, as of June 2014, has reviewed over 10,790 Internet drug outlets and found 97% of them to be out of compliance with pharmacy laws and practice standards established in the U.S. to protect the public health. Of the 10,432 websites identified as "Not Recommended," nearly half offer foreign or non-Food and Drug Administration-approved drugs, many of which may be dangerous counterfeits, to unsuspecting U.S. patients. Further, health and regulatory agencies in the U.S. and abroad have reported cases of patients harmed by counterfeit, substandard, and adulterated medications distributed by illegal Internet sellers.
Among the global coalition of stakeholders behind the .pharmacy initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, FDA, Gilead Sciences, International Pharmaceutical Federation, INTERPOL, Janssen Pharmaceuticals, LegitScript, Merck/MSD, National Association of Pharmacy Regulatory Authorities, Pfizer and state boards of pharmacy.